MediWound Ltd.
MDWD
$17.71
$0.362.08%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
11/30/2025
-
MarketBeat
11/27/2025
-
Tickeron - Stocks
11/26/2025
-
GuruFocus
11/25/2025
-
Tickeron - Stocks
MediWound (MDWD, $18.12) entered Uptrend as Momentum indicator ascends above 0 level on Nov 24, 2025
11/25/2025
-
Tickeron - Stocks
11/25/2025
-
Tickeron - Stocks
11/24/2025
-
TipRanks Financial Blog
11/23/2025
-
Simply Wall St
11/21/2025
-
MarketBeat
11/21/2025
-
Insider Monkey
11/21/2025
-
GuruFocus
11/21/2025
-
The Fly
11/21/2025
-
Tickeron - Stocks
11/21/2025
-
Tickeron - Stocks
11/20/2025
-
GuruFocus
11/20/2025
-
GuruFocus
11/20/2025
-
Seeking Alpha: Transcripts
11/20/2025
-
Seeking Alpha - Israel Stocks
11/20/2025
-
SeekingAlpha
11/20/2025
-
TipRanks Financial Blog
11/20/2025
-
Tickeron - Stocks
11/20/2025
-
Zacks Investment Research
11/20/2025
-
Nasdaq News: Stocks
11/20/2025
-
GuruFocus
11/20/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, August 14, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 24 and 28 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 7 797 14100
Address
42 Hayarkon Street
Yavne, 8122745
Yavne, 8122745
Country
Year Founded
Business Description
Sector
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States...
more